• LAST PRICE
    2.1100
  • TODAY'S CHANGE (%)
    Trending Up0.0700 (3.4314%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    2.0300 / 2.0400
  • Day Range
    Low 2.0300
    High 2.2300
  • 52 Week Range
    Low 1.0000
    High 8.8900
  • Volume
    478,916
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 2.04
TimeVolumeIMRX
09:32 ET139602.05
09:33 ET382572.06
09:39 ET93532.07
09:42 ET3002.07
09:44 ET210942.1
09:46 ET111572.15
09:48 ET13782.15
09:50 ET125362.1107
09:51 ET150832.1196
09:55 ET63602.1
09:57 ET43002.1
10:00 ET98902.0601
10:02 ET53002.04
10:08 ET27742.0693
10:09 ET21402.0908
10:13 ET45752.12
10:15 ET4502.1
10:18 ET11892.1235
10:22 ET3002.124
10:24 ET6812.1262
10:26 ET54992.13
10:29 ET15312.11
10:33 ET27702.1
10:36 ET4002.1
10:38 ET51502.0838
10:45 ET32142.11
10:49 ET5002.1132
10:54 ET17502.1309
10:58 ET3102.13
11:00 ET30942.14
11:02 ET4502.1452
11:03 ET50002.14
11:07 ET18002.148
11:09 ET33312.16
11:12 ET47082.1536
11:14 ET68792.1693
11:16 ET314312.21
11:18 ET206332.19
11:20 ET8992.189
11:23 ET12542.17
11:25 ET11242.1698
11:30 ET2002.164
11:38 ET3722.1796
11:39 ET83392.17
11:41 ET13442.17
11:48 ET2312.15
11:50 ET8502.1595
11:52 ET21542.15
11:56 ET8082.122
11:57 ET7002.1391
11:59 ET1002.13
12:01 ET4002.14
12:06 ET2342.14
12:08 ET1002.13
12:10 ET3002.14
12:14 ET4752.13
12:21 ET26132.13
12:26 ET6002.1346
12:30 ET3502.13
12:33 ET1002.12
12:39 ET2002.13
12:42 ET20352.15
12:46 ET63762.1574
12:50 ET2422.16
12:51 ET14002.15
01:04 ET2502.13
01:15 ET13952.15
01:20 ET17502.1598
01:29 ET1002.16
01:33 ET18392.1608
01:38 ET1092.1608
01:45 ET11002.1612
01:54 ET2002.1624
01:56 ET6392.1775
02:02 ET23592.1898
02:03 ET6002.185
02:05 ET7842.19
02:07 ET1002.17
02:09 ET20992.174
02:18 ET7002.19
02:20 ET17002.18
02:25 ET120002.1799
02:27 ET1912.185
02:30 ET67342.185
02:32 ET1002.1851
02:34 ET9152.179
02:36 ET206982.1899
02:38 ET452182.225
02:39 ET123002.207
02:41 ET23802.19
02:43 ET30002.18
02:56 ET6252.18
02:57 ET10902.17
03:01 ET1002.17
03:08 ET4622.17
03:14 ET9562.1601
03:15 ET1542.1504
03:17 ET39902.16
03:21 ET10002.16
03:32 ET22502.159
03:44 ET3002.1281
03:46 ET18002.1392
03:48 ET38402.14
03:50 ET8202.15
03:51 ET5832.12
03:53 ET23042.1273
03:55 ET8262.12
03:57 ET65172.115
04:00 ET107752.11
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesIMRX
Immuneering Corp
62.6M
-1.1x
---
United StatesRTGN
RetinalGenix Technologies Inc
63.0M
-15.3x
---
United StatesXFOR
X4 Pharmaceuticals Inc
62.1M
-4.3x
---
United StatesENTX
Entera Bio Ltd
59.7M
-6.2x
---
United StatesALVR
Allovir Inc
65.9M
-0.7x
---
United StatesBCAB
Bioatla Inc
67.2M
-0.8x
---
As of 2024-11-22

Company Information

Immuneering Corporation is a clinical-stage oncology company. The Company is engaged in the development of medicines for cancer patients with universal-RAS therapy. The Company’s lead product candidate, IMM-1-104, in under Phase I/IIa clinical trial in patients with advanced solid tumors harboring RAS mutations. IMM-1-104 is being developed as a once-daily oral monotherapy that aims to achieve universal-RAS activity through deep cyclic inhibition of the MAPK pathway. The Company’s second product candidate, IMM-6-415, aims to achieve universal-MAPK activity with an accelerated twice-daily oral dosing cadence, also through deep cyclic inhibition of the MAPK pathway. IMM-6-415 is in Investigational New Drug application (IND), enabling studies. Its pipeline also includes Trifecta MEK, RAS modulators and other small molecule drug discovery programs. The Company’s platform is enabled by two key elements: Bioinformatics and 3D Tumor Modeling.

Contact Information

Headquarters
245 Main St Fl 2CAMBRIDGE, MA, United States 02142
Phone
617-500-8080
Fax
302-655-5049

Executives

Independent Chairman of the Board
Ann Berman
President, Chief Executive Officer, Co-Founder, Director
Benjamin Zeskind
Chief People Officer
Leah Neufeld
Chief Accounting Officer, Treasurer
Mallory Morales
Chief Scientific Officer
Brett Hall

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$62.6M
Revenue (TTM)
$0.00
Shares Outstanding
29.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.35
EPS
$-1.97
Book Value
$3.09
P/E Ratio
-1.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.